Aspirin challenge in patients with chronic rhinosinusitis with polyps correlates with local and systemic inflammatory markers

Boaz Forer, Roee Landsberg, Shmuel Kivity*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Acetylsalicylic acid (ASA; aspirin) is a well-known inducer of pseudoallergic response in patients with chronic rhinosinusitis with polyps (CRSwPs). The mechanism that leads to this response remains unclear. This study was designed to measure and compare the local and systemic inflammatory response to aspirin challenge in patients with CRSwPs who develop either a nasobronchial response (NBR) or a nasal response (NR), and compare it with nonresponders (non-Rs). Methods: The three groups underwent nasal wash before ASA challenge, and inflammatory mediators were measured in the nasal wash as well as in serum. Results: A total of 25 CRSwP patients were enrolled. The NBR patients (n = 13) had a significantly longer mean disease duration and a higher mean serum leukotriene E4 (LTE4) level than the NR (n = 6) and non-R (n = 6) patients (39.2 ± 9.7 months, 21 ± 8.8 months, and 22.8 ± 11.2 months, respectively, and 4221 ± 1205 pg/mL, 1430 ± 605 pg/mL, and 857 ± 461 pg/mL, respectively). The NBR and NR patients had a larger mean number of nasal eosinophils than the non-R group (52.8 ± 28.8 cells/μL, 47 ± 21.3 cells/μL, and 19.3 ±13.4 cells/μL, respectively). The tryptase, albumin, nasal LTE4, and prostaglandin E2 levels were not significantly different between the three groups in any examined combination. Conclusion: The nasal eosinophil and serum LTE4 levels correlate with aspirin sensitivity.

Original languageEnglish
Pages (from-to)e170-e173
JournalAmerican Journal of Rhinology and Allergy
Volume27
Issue number6
DOIs
StatePublished - Nov 2013

Fingerprint

Dive into the research topics of 'Aspirin challenge in patients with chronic rhinosinusitis with polyps correlates with local and systemic inflammatory markers'. Together they form a unique fingerprint.

Cite this